Results 11 to 20 of about 54,841 (223)

Acute hepatotoxicity of intravenous amiodarone in a Becker muscular dystrophy patient with decompensated heart failing and ABCB4 gene mutation: as assessed for causality using the updated RUCAM [PDF]

open access: yesJournal of Cardiothoracic Surgery
Background Cardiac dysfunction, including arrhythmias, may be one of the main clinical manifestations of Becker muscular dystrophy (BMD). Amiodarone is widely used to treat arrhythmia.
Hui Shi   +3 more
doaj   +2 more sources

Atypical reaction to anesthesia in Duchenne/Becker muscular dystrophy [PDF]

open access: yesRevista Brasileira de Anestesiologia, 2018
Background and objectives Duchenne/Becker muscular dystrophy affects skeletal muscles and leads to progressive muscle weakness and risk of atypical anesthetic reactions following exposure to succinylcholine or halogenated agents.
Helga Cristina Almeida da Silva   +5 more
doaj   +6 more sources

Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis

open access: yesJournal of Orthopaedic Surgery and Research, 2022
Background A variety of mutations in the largest human gene, dystrophin, cause a spectrum from mild to severe dystrophin-associated muscular dystrophies.
N. Salari   +7 more
semanticscholar   +1 more source

A review of diagnosis of Duchenne and Becker muscular dystrophy [PDF]

open access: yesĶazaķstannyṇ Klinikalyķ Medicinasy, 2021
Duchenne muscular dystrophy and Becker muscular dystrophy are progressive serious neuromuscular disorders. We have reviewed contemporary data on diagnosis of DMD and BMD. Searches were carried out from 2010 to 2020. This article discusses clinical signs,
Dana Chunkayeva, Altynshash Jaxybayeva
doaj   +1 more source

Diffusion‐tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2023
Becker muscular dystrophy (BMD) is an X‐linked disorder characterized by slow, progressive muscle damage and muscle weakness. Hallmarks include fibre‐size variation and replacement of skeletal muscle with fibrous and adipose tissues, after repeated ...
D. Cameron   +15 more
semanticscholar   +1 more source

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study

open access: yesFrontiers in Neurology, 2023
Objective No treatments are approved for Becker muscular dystrophy (BMD). This study investigated the efficacy and safety of givinostat, a histone deacetylase pan-inhibitor, in adults with BMD.
G. Comi   +14 more
semanticscholar   +1 more source

Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy

open access: yesHuman Mutation, 2022
DMD pathogenic variants for Duchenne and Becker muscular dystrophy are detectable with high sensitivity by standard clinical exome analyses of genomic DNA.
M. Waldrop   +22 more
semanticscholar   +1 more source

Patients With Becker Muscular Dystrophy Have Severe Paraspinal Muscle Involvement

open access: yesFrontiers in Neurology, 2021
Introduction: Paraspinal muscles are important for gross motor functions. Impairment of these muscles can lead to poor postural control and ambulation difficulty.
Aisha M. Sheikh   +5 more
doaj   +1 more source

Muscle histological changes in a large cohort of patients affected with Becker muscular dystrophy

open access: yesActa Neuropathologica Communications, 2022
Becker muscular dystrophy (BMD) is a severe X-linked muscle disease. Age of onset, clinical variability, speed of progression and affected tissues display wide variability, making a clinical trial design for drug development very complex.
M. Ripolone   +13 more
semanticscholar   +1 more source

Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay

open access: yesScientific Reports, 2021
Becker muscular dystrophy (BMD) is the milder allelic variant of Duchenne muscular dystrophy, with higher dystrophin levels. To anticipate on results of interventions targeting dystrophin expression it is important to know the natural variation of ...
Z. Koeks   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy